May 15, 2007

More than 150 agenda items underwent Executive Board scrutiny, April 12-14 at AVMA headquarters in Schaumburg, Ill. Dr. James O. Cook of District V, Lebanon, Ky., chaired the meeting.

AVMA News

Policy on unapproved new animal drugs as devices passes Printer-friendly version The Executive Board approved a policy on unapproved new animal drugs marketed as devices, as defined by the Food and Drug Administration. The policy reads as follows: Unapproved New Animal Drugs Marketed as Devices The AVMA encourages the FDA to take greater enforcement action in regulating the marketing of products represented as devices as defined by the FDA to the veterinary profession but that appear to be unapproved new animal drugs. The AVMA Council on Biologic and Therapeutic Agents submitted the recommendation. The council reported that some sponsors of approved human medical devices and some makers of veterinary medical devices are ascribing and promot ...

Companion Animals

Melamine adulterates three ingredients in pet food Printer-friendly version Melamine appears to have adulterated three high-protein ingredients from China that went into pet food. In late April, the Food and Drug Administration was investigating the theory that the adulteration was purposeful, among other possibilities. Adding melamine to an ingredient could increase the protein reading during chemical analysis. The FDA detected melamine originally in wheat gluten and more recently in rice protein concentrate from China that went into pet food for the U.S. market. Royal Canin detected melamine in corn gluten from China that went into pet food for the South African market, according to media reports. Natural Balance Pet Foods was first to an ...